1. |
张媛, 杨林花. 血友病治疗研究进展. 血栓与止血学, 2006, 12(6): 279-281.
|
2. |
Smith PS, Levine PH. The benefits of comprehensive care of hemophilia: A five-year study of outcome. American Journal of Public Health, 1984, 74(6): 616-617.
|
3. |
余运西. 七成血友病患者得不到正确诊断. Available from: http://www.xueyou.org/china/xinwen/xy/ 201107/363.shtml.
|
4. |
Drummond MF, Jefferson T. Guidelines for authors and peer reviewers of economic submissions to the BMJ. BMJ, 1996, 313(7052): 275-283.
|
5. |
孙汉英, 徐惠珍, 杨世海. 汉口地区血友病调查报告. 华中科技大学学报(医学版). 1989, (S2): 139-141.
|
6. |
郭瑞祥, 张云禾. 冷沉淀治疗甲型血友病1例. 重庆医学, 1989, 18(1): 64.
|
7. |
胡超英, 胡耀文. 母体全脾移植治疗重型血友病甲的观察及护理. 护理学杂志, 1993, (1): 3-4.
|
8. |
姜洪池, 朱安龙, 许军, 等. 活体供脾脾脏移植治疗血友病甲5例. 中华肝胆外科杂志, 2001, 7(8): 475-477.
|
9. |
张雪芹, 王勤友, 丁培芳, 等. 302例血友病甲因子Ⅷ用量的统计分析. 中国输血杂志, 2001, 14(2): 81.
|
10. |
徐瑞焱. <’32>P胶体滑膜切除术治疗慢性血友病滑膜炎. 北京: 中国协和医科大学, 2003.
|
11. |
Wang T, Zhang L, Li H. Assessing health-related quality-of-life in individuals with haemophilia in China. Haemophilia, 2004, 10(4): 370-375.
|
12. |
王翠琴, 付雪玲, 丁丽莎. 46例血友病A家庭治疗的经验. 中华医学实践杂志, 2005, 4(10): 1067.
|
13. |
钟小红. 血友病儿童低剂量替代治疗综合关怀模式研究. 广州: 第一军医大学, 2007.
|
14. |
范永前, 冯建民, 杨庆铭, 等. 全膝关节置换术治疗血友病膝关节病. 中华骨科杂志, 2007, 27(10): 731-735.
|
15. |
吴润晖, 吴心怡, 冯涛, 等. 儿童血友病病人临床资料及现状分析. 血栓与止血学, 2008, 14(3): 116-120.
|
16. |
李文卿. 重组人凝血因子Ⅷ在中国血友病A患者的有效性及抑制物产生的追踪观察. 广州:南方医科大学, 2008.
|
17. |
李敏. 血友病A儿童短期低剂量预防治疗的观察. 广州: 南方医科大学, 2009.
|
18. |
李进凤, 曾旋辉, 黄琴, 等. 广东血友病患者医疗保险现状调查. 卫生经济研究, 2010, (12): 37-39.
|
19. |
钟小红, 周春兰, 周宏珍, 等. 血友病患者诊疗及健康状况调查分析. 护理学杂志, 2010, 25(11): 23-26.
|
20. |
Wu R, Luke K H, Poon M C, et al. Low dose secondary prophylaxis reduces joint bleeding in severe and moderate haemophilic children: A pilot study in China. Haemophilia, 2011, 17: 70-74.
|
21. |
Wu RH, Wu XY, Zhang NN, et al. Evaluation clinical data and current condition of children hemophilic patients in China. Chinese Journal of Thrombosis and Hemostasis, 2008, 14(3): 116-120.
|
22. |
丁秋兰, 王学锋, 王鸿利, 等. 血友病诊断和治疗的专家共识. 临床血液学杂志, 2010, 23(1): 49-53.
|
23. |
Globe DR, Curtis RG, Koerper MA, et al. Utilization of care in haemophilia: a resource-based method for cost analysis from the Haemophilia Utilization Group Study (HUGS). Haemophilia, 2004, 10(s1): 63-70.
|
24. |
Kar A, Potnis Lele M. Descriptive epidemiology of haemophilia in Maharashtra, India. Haemophilia, 2001, 7(6): 561-567.
|
25. |
Soucie JM, Symons JIV, Evantt B, et al. Home-based factor infusion therapy and hospitalization for bleeding complication among males with hemophilia. Haemophilia, 2001, 7(2): 198-200.
|
26. |
Khoriaty R, Taher A, Inati A, et al. A comparison between prophylaxis and on demand treatment for severe haemophilia. Clinical & Laboratory Haematology, 2005, 27: 320-323.
|
27. |
Liou WS, Tu TC, Cheng SN, et al. Secondary prophylaxis treatment versus on-demand treatment for patients with severe haemophilia A: Comparisons of cost and outcomes in Taiwan. Haemophilia, 2011, 17(1): 45-54.
|